Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam Koopman

Showing results (81-90 of 193) with videos related to

Pageof 20
Sort By:
International Journal of Cancer|November 8, 2022
Time-varying prognostic value of primary tumor sidedness in metastatic colorectal cancer: A population-based study and meta-analysisDave E W van der Kruijssen, Auke J S van der Kuil, Geraldine R Vink, et al.
Digestive Surgery|July 28, 2021
Role of Up-Front Primary Tumor Resection and Tumor Sidedness in the Survival of Synchronous Metastatic Colon Cancer PatientsDave E W van der Kruijssen, Karlijn L van Rooijen, Sophie A Kurk, et al.
BMC Medical Informatics and Decision Making|December 16, 2018
Inventory of oncologists' unmet needs for tools to support decision-making about palliative treatment for metastatic colorectal cancerEllen G Engelhardt, Dóra Révész, Hans J Tamminga, et al.
Mutation Research|November 14, 2013
Excision Repair Cross-Complementation group 1 (ERCC1) C118T SNP does not affect cellular response to oxaliplatinLieke H van Huis-Tanja, Dina M Kweekel, Xiaobo Lu, et al.
Scientific Reports|February 17, 2021
The Prospective Dutch Colorectal Cancer (PLCRC) cohort: real-world data facilitating research and clinical careJeroen W G Derksen, Geraldine R Vink, Marloes A G Elferink, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 23, 2022
Evaluation of an individual feedback report on patient-reported outcomes in the Prospective Dutch ColoRectal Cancer cohortPauline A J Vissers, Geraldine R Vink, Maaike R Koelink, et al.
Oncotarget|September 3, 2015
Reduced rate of copy number aberrations in mucinous colorectal carcinomaNiek Hugen, Femke Simmer, Leonie J M Mekenkamp, et al.
International Journal of Cancer|May 3, 2024
Associations between low- and high-fat dairy intake and recurrence risk in people with stage I-III colorectal cancer differ by sex and primary tumour locationAnne-Sophie van Lanen, Dieuwertje E Kok, Evertine Wesselink, et al.
International Journal of Cancer|March 13, 2025
Real-world treatment patterns and outcomes based on RAS/BRAF status in metastatic colorectal cancer-Analysis of the Prospective Dutch Colorectal Cancer cohortSietske C M W van Nassau, Koen Zwart, Frederieke H van der Baan, et al.
Cancers|October 27, 2022
External Validation of the Colon Life Nomogram for Predicting 12-Week Mortality in Dutch Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil in Daily PracticePatricia A H Hamers, G Emerens Wensink, Maarten van Smeden, et al.
Pageof 20

Showing results (81-90 of 193) with videos related to

Sort By:
Pageof 20
International Journal of Cancer|November 8, 2022
Time-varying prognostic value of primary tumor sidedness in metastatic colorectal cancer: A population-based study and meta-analysisDave E W van der Kruijssen, Auke J S van der Kuil, Geraldine R Vink, et al.
Digestive Surgery|July 28, 2021
Role of Up-Front Primary Tumor Resection and Tumor Sidedness in the Survival of Synchronous Metastatic Colon Cancer PatientsDave E W van der Kruijssen, Karlijn L van Rooijen, Sophie A Kurk, et al.
BMC Medical Informatics and Decision Making|December 16, 2018
Inventory of oncologists' unmet needs for tools to support decision-making about palliative treatment for metastatic colorectal cancerEllen G Engelhardt, Dóra Révész, Hans J Tamminga, et al.
Mutation Research|November 14, 2013
Excision Repair Cross-Complementation group 1 (ERCC1) C118T SNP does not affect cellular response to oxaliplatinLieke H van Huis-Tanja, Dina M Kweekel, Xiaobo Lu, et al.
Scientific Reports|February 17, 2021
The Prospective Dutch Colorectal Cancer (PLCRC) cohort: real-world data facilitating research and clinical careJeroen W G Derksen, Geraldine R Vink, Marloes A G Elferink, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 23, 2022
Evaluation of an individual feedback report on patient-reported outcomes in the Prospective Dutch ColoRectal Cancer cohortPauline A J Vissers, Geraldine R Vink, Maaike R Koelink, et al.
Oncotarget|September 3, 2015
Reduced rate of copy number aberrations in mucinous colorectal carcinomaNiek Hugen, Femke Simmer, Leonie J M Mekenkamp, et al.
International Journal of Cancer|May 3, 2024
Associations between low- and high-fat dairy intake and recurrence risk in people with stage I-III colorectal cancer differ by sex and primary tumour locationAnne-Sophie van Lanen, Dieuwertje E Kok, Evertine Wesselink, et al.
International Journal of Cancer|March 13, 2025
Real-world treatment patterns and outcomes based on RAS/BRAF status in metastatic colorectal cancer-Analysis of the Prospective Dutch Colorectal Cancer cohortSietske C M W van Nassau, Koen Zwart, Frederieke H van der Baan, et al.
Cancers|October 27, 2022
External Validation of the Colon Life Nomogram for Predicting 12-Week Mortality in Dutch Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil in Daily PracticePatricia A H Hamers, G Emerens Wensink, Maarten van Smeden, et al.
Pageof 20